financetom
Business
financetom
/
Business
/
--3M to Pay Quarterly Dividend $0.70 a Share, Payable June 12 to Shareholders of Record May 24
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--3M to Pay Quarterly Dividend $0.70 a Share, Payable June 12 to Shareholders of Record May 24
May 14, 2024 2:03 PM

04:36 PM EDT, 05/14/2024 (MT Newswires) --

Price: 99.31, Change: -0.77, Percent Change: -0.77

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Microsoft prepared to walk away from high-stakes talks with OpenAI, FT reports
Microsoft prepared to walk away from high-stakes talks with OpenAI, FT reports
Jun 18, 2025
(Reuters) -Microsoft ( MSFT ) is prepared to walk away from its high-stakes talks with OpenAI over the future of its multibillion-dollar alliance, the Financial Times reported on Wednesday. The tech giant has considered halting complex discussions with the ChatGPT maker if the two sides remain unable to agree on critical issues such as the size of Microsoft's ( MSFT...
Incyte's Drug to Treat Follicular Lymphoma Receives FDA Approval
Incyte's Drug to Treat Follicular Lymphoma Receives FDA Approval
Jun 18, 2025
04:00 PM EDT, 06/18/2025 (MT Newswires) -- Incyte ( INCY ) said Wednesday it received US Food and Drug Administration approval for its Monjuvi monoclonal antibody, in combination with rituximab and lenalidomide, to treat adults with follicular lymphoma. The priority review and FDA approval of the supplemental biologics license application for Monjuvi was based on phase 3 trial data evaluating...
Nike delays launch of women's brand in partnership with Kim Kardashian's Skims
Nike delays launch of women's brand in partnership with Kim Kardashian's Skims
Jun 18, 2025
June 18 (Reuters) - Nike's ( NKE ) launch of a new women's activewear brand in the U.S. through a partnership with Kim Kardashian-owned shapewear label Skims has been delayed, the Air Jordan maker's spokesperson told Reuters on Wednesday. The partnership, which was announced in February, is part of new CEO Elliott Hill's plan to turn the struggling company around...
Copyright 2023-2026 - www.financetom.com All Rights Reserved